The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)

Eur Respir J. 2021 Dec 31;59(1):2101296. doi: 10.1183/13993003.01296-2021. Print 2022 Jan.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Asthma* / drug therapy
  • Bronchial Hyperreactivity* / drug therapy
  • Bronchial Provocation Tests
  • Humans
  • Mannitol
  • Respiratory Hypersensitivity*

Substances

  • Antibodies, Monoclonal, Humanized
  • Mannitol
  • tezepelumab

Associated data

  • ClinicalTrials.gov/NCT02698501